POTEN-C Trial

Preliminary Results from the POTEN-C Trial – ESTRO

European SocieTy for Radiotherapy and Oncology (ESTRO) shared a post on X:

“Can radiotherapy preserve sexual function in prostate cancer patients? Early results from the POTEN-C trial, presented at ESTRO25, suggest yes. Neurovascular-sparing SAbR led to less toxicity and better early QoL outcomes.”

Read further.

Preliminary Results from the POTEN-C Trial - ESTRO

More posts featuring ESTRO.

cancer ESTRO ESTRO25 European SocieTy for Radiotherapy and Oncology OncoDaily Oncology POTEN-C trial prostate cancer radiotherapy